MiniMed $560 million IPO
The carve-out IPO of Medtronic’s diabetes unit is the second largest medtech IPO ever
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
One Call acquisition of Data Dimensions
We are advising One Call on the transaction
Coloplast acquisition of Uromedica
We are advising Coloplast on the transaction
AgomAb Therapeutics $200 million IPO
We advised the representatives of the several underwriters on the IPO
Eikon Therapeutics $381 million IPO
We advised the representatives of the several underwriters on the IPO
AbelZeta sale of China rights to GPC3 CAR-T therapy to AstraZeneca
We advised AbelZeta on the transaction
Penumbra $14.5 billion sale to Boston Scientific
We are advising Penumbra on the transaction
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
W. L. Gore & Associates acquisition of Conformal Medical
We are advising Gore on the transaction
GSK strategic collaboration with CAMP4 Therapeutics
We advised GSK on the transaction